![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 11, 6935-6945, March 12, 1999
From the Department of Immunology and Oncology, Centro Nacional de
Biotecnología, Consejo Superior de Investigaciones
Científicas, Universidad Autónoma de Madrid, Campus de
Cantoblanco, E-28049 Madrid, Spain
The androgen-independent human prostate
adenocarcinoma cell line DU-145 proliferates in serum-free medium and
produces insulin-like growth factors (IGF)-I, IGF-II, and the IGF
type-1 receptor (IGF-1R). They also secrete three IGF-binding proteins
(IGFBP), IGFBP-2, -3, and -4. Of these, immunoblot analysis revealed
selective proteolysis of IGFBP-3, yielding fragments of 31 and 19 kDa.
By using an anti-IGF-I-specific monoclonal antibody (mAb), we detect
surface receptor-bound IGF-I on serum-starved DU-145 cells, which
activates IGF-1R and triggers a mitogenic signal. Incubation of DU-145
cells with blocking anti-IGF-I, anti-IGF-II, or anti-IGF-I plus
anti-IGF-II mAb does not, however, inhibit serum-free growth of DU-145.
Conversely, anti-IGF-1R mAb and IGFBP-3 inhibit DNA synthesis. IGFBP-3
also modifies the DU-145 cell cycle, decreases p34cdc2 levels,
and IGF-1R autophosphorylation. The antiproliferative IGFBP-3 activity is not IGF-independent, since
des-(1-3)IGF-I, which does not bind to IGFBP-3, reverses its
inhibitory effect. DU-145 also secretes the matrix metalloproteinase
(MMP)-9, which can be detected in both a soluble and a membrane-bound
form. Matrix metalloproteinase inhibitors, but not serpins, abrogate
DNA synthesis in DU-145 associated with the blocking of IGFBP-3
proteolysis. Overexpression of an antisense cDNA for MMP-9 inhibits
80% of DU-145 cell proliferation that can be reversed by IGF-I in a
dose-dependent manner. Inhibition of MMP-9 expression is
also associated with a decrease in IGFBP-3 proteolysis and with reduced
signaling through the IGF-1R. Our data indicate an IGF autocrine loop
operating in DU-145 cells, specifically modulated by IGFBP-3, whose
activity may in turn be regulated by IGFBP-3 proteases such as
MMP-9.
This article has been cited by other articles:
![]() |
G. S. Butler, R. A. Dean, E. M. Tam, and C. M. Overall Pharmacoproteomics of a Metalloproteinase Hydroxamate Inhibitor in Breast Cancer Cells: Dynamics of Membrane Type 1 Matrix Metalloproteinase-Mediated Membrane Protein Shedding Mol. Cell. Biol., August 1, 2008; 28(15): 4896 - 4914. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Piccard, P. E. Van den Steen, and G. Opdenakker Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins J. Leukoc. Biol., April 1, 2007; 81(4): 870 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Samani, S. Yakar, D. LeRoith, and P. Brodt The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights Endocr. Rev., February 1, 2007; 28(1): 20 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Theocharis, C. Seidel, M. Borset, K. Dobra, V. Baykov, V. Labropoulou, I. Kanakis, E. Dalas, N. K. Karamanos, A. Sundan, et al. Serglycin Constitutively Secreted by Myeloma Plasma Cells Is a Potent Inhibitor of Bone Mineralization in Vitro J. Biol. Chem., November 17, 2006; 281(46): 35116 - 35128. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mitsui, S. Mochizuki, T. Kodama, M. Shimoda, T. Ohtsuka, T. Shiomi, M. Chijiiwa, T. Ikeda, M. Kitajima, and Y. Okada ADAM28 Is Overexpressed in Human Breast Carcinomas: Implications for Carcinoma Cell Proliferation through Cleavage of Insulin-like Growth Factor Binding Protein-3. Cancer Res., October 15, 2006; 66(20): 9913 - 9920. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Leibowitz-Amit, G. Tsarfaty, Y. Abargil, G. M. Yerushalmi, J. Horev, and I. Tsarfaty Mimp, a Mitochondrial Carrier Homologue, Inhibits Met-HGF/SF-Induced Scattering and Tumorigenicity by Altering Met-HGF/SF Signaling Pathways. Cancer Res., September 1, 2006; 66(17): 8687 - 8697. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nosho, M. Yoshida, H. Yamamoto, H. Taniguchi, Y. Adachi, M. Mikami, Y. Hinoda, and K. Imai Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis Carcinogenesis, May 1, 2005; 26(5): 892 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Masaki, T. Kurisaki, K. Shirakawa, and A. Sehara-Fujisawa Role of Meltrin {alpha} (ADAM12) in Obesity Induced by High- Fat Diet Endocrinology, April 1, 2005; 146(4): 1752 - 1763. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Qiao, P. Shapiro, R. Kumar, and A. Passaniti Insulin-like Growth Factor-1 Regulates Endogenous RUNX2 Activity in Endothelial Cells through a Phosphatidylinositol 3-Kinase/ERK-dependent and Akt-independent Signaling Pathway J. Biol. Chem., October 8, 2004; 279(41): 42709 - 42718. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Van Valckenborgh, P. I. Croucher, H. De Raeve, C. Carron, E. De Leenheer, S. Blacher, L. Devy, A. Noel, E. De Bruyne, K. Asosingh, et al. Multifunctional Role of Matrix Metalloproteinases in Multiple Myeloma: A Study in the 5T2MM Mouse Model Am. J. Pathol., September 1, 2004; 165(3): 869 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Stearns, G. Kim, F. Garcia, and M. Wang Interleukin-10 Induced Activating Transcription Factor 3 Transcriptional Suppression of Matrix Metalloproteinase-2 Gene Expression in Human Prostate CPTX-1532 Cells Mol. Cancer Res., July 1, 2004; 2(7): 403 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mira, R. A. Lacalle, J. M. Buesa, G. G. de Buitrago, S. Jimenez-Baranda, C. Gomez-Mouton, C. Martinez-A, and S. Manes Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface J. Cell Sci., May 1, 2004; 117(9): 1847 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.'i. Miyamoto, K. Yano, S. Sugimoto, G. Ishii, T. Hasebe, Y. Endoh, K. Kodama, M. Goya, T. Chiba, and A. Ochiai Matrix Metalloproteinase-7 Facilitates Insulin-Like Growth Factor Bioavailability through Its Proteinase Activity on Insulin-Like Growth Factor Binding Protein 3 Cancer Res., January 15, 2004; 64(2): 665 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sadowski, S. Dietrich, F. Koschinsky, and R. Sedlacek Matrix Metalloproteinase 19 Regulates Insulin-like Growth Factor-mediated Proliferation, Migration, and Adhesion in Human Keratinocytes through Proteolysis of Insulin-like Growth Factor Binding Protein-3 Mol. Biol. Cell, November 1, 2003; 14(11): 4569 - 4580. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Turner, A. L. Harris, S. Melmed, and J. A. H. Wass Angiogenesis in Endocrine Tumors Endocr. Rev., October 1, 2003; 24(5): 600 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kiyama, K. Morrison, T. Zellweger, M. Akbari, M. Cox, D. Yu, H. Miyake, and M. E. Gleave Castration-Induced Increases in Insulin-Like Growth Factor-Binding Protein 2 Promotes Proliferation of Androgen-independent Human Prostate LNCaP Tumors Cancer Res., July 1, 2003; 63(13): 3575 - 3584. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Andl, T. Mizushima, H. Nakagawa, K. Oyama, H. Harada, K. Chruma, M. Herlyn, and A. K. Rustgi Epidermal Growth Factor Receptor Mediates Increased Cell Proliferation, Migration, and Aggregation in Esophageal Keratinocytes in Vitro and in Vivo J. Biol. Chem., January 10, 2003; 278(3): 1824 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Firth and R. C. Baxter Cellular Actions of the Insulin-Like Growth Factor Binding Proteins Endocr. Rev., December 1, 2002; 23(6): 824 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Chang, K. Gong, S. Sun, D. Liu, A. K. El-Naggar, F. R. Khuri, W. K. Hong, and H.-Y. Lee Clinical Significance of Insulin-like Growth Factor-binding Protein-3 Expression in Stage I Non-Small Cell Lung Cancer Clin. Cancer Res., December 1, 2002; 8(12): 3796 - 3802. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yu, K. Pan, D. Xing, G. Liang, W. Tan, L. Zhang, and D. Lin Correlation between a Single Nucleotide Polymorphism in the Matrix Metalloproteinase-2 Promoter and Risk of Lung Cancer Cancer Res., November 15, 2002; 62(22): 6430 - 6433. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lambert, C. Munaut, M. Jost, A. Noel, Z. Werb, J.-M. Foidart, and J.-M. Rakic Matrix Metalloproteinase-9 Contributes to Choroidal Neovascularization Am. J. Pathol., October 1, 2002; 161(4): 1247 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hashimoto, I. Inoki, Y. Fujii, T. Aoki, E. Ikeda, and Y. Okada Matrix Metalloproteinases Cleave Connective Tissue Growth Factor and Reactivate Angiogenic Activity of Vascular Endothelial Growth Factor 165 J. Biol. Chem., September 20, 2002; 277(39): 36288 - 36295. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ma, H. Qin, and E. N. Benveniste Transcriptional Suppression of Matrix Metalloproteinase-9 Gene Expression by IFN-{gamma} and IFN-{beta}: Critical Role of STAT-1{alpha} J. Immunol., November 1, 2001; 167(9): 5150 - 5159. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Guo, S. Liu, R. F. Spurney, and L. D. Quarles Analysis of recombinant Phex: an endopeptidase in search of a substrate Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E837 - E847. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yu and T. Rohan Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression J Natl Cancer Inst, September 20, 2000; 92(18): 1472 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Moore, R. Garg, C. Johnson, M. J. Coptcoat, A. J. Ridley, and J. D. H. Morris PSK, a Novel STE20-like Kinase Derived from Prostatic Carcinoma That Activates the c-Jun N-terminal Kinase Mitogen-activated Protein Kinase Pathway and Regulates Actin Cytoskeletal Organization J. Biol. Chem., February 11, 2000; 275(6): 4311 - 4322. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Feldser, F. Agani, N. V. Iyer, B. Pak, G. Ferreira, and G. L. Semenza Reciprocal Positive Regulation of Hypoxia-inducible Factor 1{{alpha}} and Insulin-like Growth Factor 2 Cancer Res., August 1, 1999; 59(16): 3915 - 3918. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |